IntraClude
Commercial- Indications
- Cardiopulmonary bypass
Company intelligence / Profile preview
enableCV develops and markets innovative medical devices that support minimally invasive cardiovascular surgeries. Its portfolio includes commercialized products such as intra-aortic occlusion devices, retrograde cardioplegia delivery systems, and arterial cannulae used globally by cardiac surgeons.
2 more assets in the full pipeline.
Request access →Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on enableCV.